Unit of Psychiatry, Department of Medicine (DAME), University of Udine, Udine 33100, Italy.
Department of Psychosis Studies, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London SE5 8AF, UK.
Curr Neuropharmacol. 2024;22(3):495-520. doi: 10.2174/1570159X21666230801150032.
The diathesis-stress paradigm and the cannabinoid-hypothesis have been proposed as possible pathophysiological models of schizophrenia. However, they have historically been studied independently of each other.
This PRISMA 2020-compliant systematic review aimed at reappraising the interplay between the hypothalamic-pituitary-adrenal (HPA) axis and the endocannabinoid (eCB) system in psychosis- spectrum disorder risk and outcome.
All pathophysiological and outcome clinical studies, concomitantly evaluating the two systems in psychosis-spectrum disorder risk and different stages of illness, were gathered from electronic databases (Pubmed, Web of Science, and Scopus), and discussed.
41 eligible outputs were extracted, focusing on at least a biological measure (9 HPA-related studies: 4 eCB-interventional, 1 HPA-interventional, 1 both HPA-interventional and non-interventional, 3 non-interventional; 2 eCB-related studies: non-interventional), environmental measures only (29 studies: 1 eCB- interventional, 28 non-interventional), and genetic measures (1 study: non-interventional). Independent contributions of aberrancies in the two systems to the physiopathology and outcome of psychosis were confirmed. Also, concomitant alterations in the two systems, either genetically defined (e.g., CNR1 genetic variation), biologically determined (e.g., dysfunctional HPA axis or endocannabinoid signaling), or behaviorally imputed (e.g., cannabis use, stress exposure, and response), were consistently reported in psychosis. Further, a complex biobehavioral perturbation was revealed not only within each system (e.g., cannabis use affecting the eCB tone, stress exposure affecting the HPA axis), but also across the two systems (e.g., THC affecting the HPA axis, childhood trauma affecting the endocannabinoid signaling).
There is a need to concomitantly study the two systems' mechanistic contribution to psychosis in order to establish more refined biological relevance.
素质-应激范式和大麻素假说被提出作为精神分裂症的可能病理生理学模型。然而,它们在历史上是相互独立研究的。
本研究遵循 PRISMA 2020 准则,旨在重新评估下丘脑-垂体-肾上腺 (HPA) 轴和内源性大麻素 (eCB) 系统在精神分裂症谱系障碍风险和结局中的相互作用。
从电子数据库(Pubmed、Web of Science 和 Scopus)中收集并讨论了所有同时评估 HPA 轴和 eCB 系统在精神分裂症谱系障碍风险和疾病不同阶段的病理生理学和临床结局的研究。
提取了 41 项符合条件的研究结果,这些研究主要集中在至少一项生物学测量上(9 项 HPA 相关研究:4 项 eCB 干预性研究、1 项 HPA 干预性研究、1 项 HPA 干预性和非干预性研究、3 项非干预性研究;2 项 eCB 相关研究:非干预性研究)、环境测量(29 项研究:1 项 eCB 干预性研究、28 项非干预性研究)和遗传测量(1 项研究:非干预性研究)。两个系统的异常对精神病的病理生理学和结局的独立贡献得到了证实。此外,两个系统的同时改变,无论是遗传定义的(例如,CNR1 遗传变异)、生物学决定的(例如,HPA 轴功能障碍或内源性大麻素信号传导)还是行为推断的(例如,大麻使用、应激暴露和反应),在精神病中都得到了一致的报道。此外,还揭示了不仅在每个系统内(例如,大麻使用影响 eCB 张力,应激暴露影响 HPA 轴),而且在两个系统之间(例如,THC 影响 HPA 轴,童年创伤影响内源性大麻素信号传导)存在复杂的生物行为干扰。
需要同时研究两个系统对精神病的机制贡献,以建立更精细的生物学相关性。